MagForce Nanotechnologies AG
Description MagForce AG, a medical technology company, operates in the field of nanomedicine in oncology. Its proprietary NanoTherm therapy enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of magnetic nanoparticles. The company also provides NanoTherm, a ferrofluid that reacts to the presence of a magnetic field; NanoPlan, the therapy planninng software; and NanoActivator, a magnetic field applicator for tumor therapy. The company offers its products under the MagForce, NanoTherm, NanoPlan, and NanoActivator trademarks. Its products under development include pancreatic and prostate carcinoma, and glioblastoma. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany. To view the detailed information, you need to SUBSCRIBE with us. |
 |